TrialBMC infectious diseases2016

The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.

Filip Jansåker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.